Loading company…
Oralead Pharma develops oral delivery technologies and drug candidates for large-molecule medicines.
Founded in 2022 and based in Shenzhen, Oralead Pharma develops oral delivery technologies for large-molecule biopharmaceuticals. Its work includes the Macoral delivery platform, Simgut in-vitro absorption evaluation technology, and oral peptide drug candidates. The company works with biopharmaceutical developers and research institutions on technology and product development. It closed a pre-Series A funding round in January 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in